Screening for chronic kidney disease can be of help to prevent atherosclerotic end-organ damage

Area of Science:

• Nephrology
• Cardiovascular Medicine
• Vascular Biology

Background:

• Atherosclerotic damage to the kidney is a leading cause of chronic kidney disease (CKD) and kidney failure.
• Kidney damage often parallels atherosclerosis in the heart, brain, and lower extremities, indicating systemic vascular disease.
• Early detection of kidney damage through albuminuria and eGFR monitoring can precede symptoms in other organs.

Discussion:

• Nephrologists are well-positioned to spearhead early detection and management strategies for CKD.
• Monitoring kidney function (albuminuria, eGFR) provides an accessible metric for assessing systemic atherosclerotic burden.
• Early intervention in CKD can mitigate progressive atherosclerotic end-organ damage.

Key Insights:

• Kidney damage is a sensitive indicator of widespread atherosclerotic disease.
• Nephrologists can play a pivotal role in coordinating preventive care for at-risk populations.
• Early detection and management of CKD are crucial for preventing cardiovascular and cerebrovascular events.

Outlook:

• Integrating nephrology expertise into primary care can enhance early identification of patients at risk.
• Improved collaboration between nephrologists, general practitioners, and healthcare workers can optimize preventive strategies.
• Focusing on kidney health may offer a proactive approach to managing systemic atherosclerosis and its complications.